Patents by Inventor Luc Rivron

Luc Rivron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS
    Publication number: 20170160287
    Abstract: Use of a radiolabelled form of 7-chloro-?/?,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4/?/?pyridazino[4,5-b]indole-1-acetamide as a biomarker for the detection, in an individual, of PBR levels associated with normal and pathological conditions. Method for the detection of PBR levels associated with normal and pathological conditions. Diagnostic kit.
    Type: Application
    Filed: November 10, 2016
    Publication date: June 8, 2017
    Inventors: Jesus BENAVIDES, Hérve BOUTIN, Marie-Noëlle CASTEL, Annelaure DAMONT, Frédéric DOLLE, Philippe HANTRAYE, Frank MARGUET, Thomas ROONEY, Luc RIVRON, Bertrand TAVITIAN, Cyrille THOMINIAUX
  • USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS
    Publication number: 20120039816
    Abstract: Use of a radiolabelled form of 7-chloro-?/,?/,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4/-/-pyridazino[4,5-b]indole-1-acetamide as a biomarker for the detection, in an individual, of PBR levels associated with normal and pathological conditions. Method for the detection of PBR levels associated with normal and pathological conditions. Diagnostic kit.
    Type: Application
    Filed: October 27, 2009
    Publication date: February 16, 2012
    Applicants: SANOFI-AVENTIS, COMMISSARIAT A L'ENERGIE ATOMIQUE
    Inventors: Jesus Benavides, Hérve Boutin, Marie-Noëlle Castel, Annelaure Damont, Frédéric Dolle, Philippe Hantraye, Frank Marguet, Thomas Rooney, Luc Rivron, Bertrand Tavitian, Cyrille Thominiaux
  • Dibenzo[b,e]oxepinacetic acid derivatives and pharmaceutical compositions containing them
    Patent number: 4810723
    Abstract: A compound, in the form of a pure optical isomer or a racemate, which is a dibenzo[be]oxepinacetic acid of the general formula (I) ##STR1## in which R1, R2 and R3, which may be the same or different, each represent hydrogen or methyl, XX represents a carbon-carbon bond or two hydrogen atoms, and YY represents a carbon-carbon bond or two hydrogen atoms, or a pharmaceutically acceptable salt thereof has useful therapeutic properties, especially as an anti-inflammatory.
    Type: Grant
    Filed: December 21, 1987
    Date of Patent: March 7, 1989
    Assignee: Synthelabo
    Inventors: Thomas Purcell, Luc Rivron, Lydia Zard